What does this research mean for the field?

Low-dose heparin prophylaxis significantly reduces the incidence of postoperative venous thromboembolism and fatal pulmonary embolism without increasing bleeding risks in general surgical patients, and should be adopted into routine clinical practice. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

What question did this study set out to answer?

This research evaluates the effectiveness of low-dose heparin in preventing thromboembolic events post-surgery.

January 1, 1978World Journal of Surgery

The current status of low‐dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism

View Full Paper

Ask AI

Bookmark

Why the study?

Does low-dose heparin prevent fatal pulmonary embolism and deep vein thrombosis in patients undergoing major surgery?

Key Points

This research evaluates the effectiveness of low-dose heparin in preventing thromboembolic events post-surgery.
Conducted a multicenter prospective randomized controlled trial with 4,121 patients
Compared 2,045 patients receiving low-dose heparin to 2,076 in the control group
Analyzed postoperative bleeding and blood transfusion in 1,475 patients.
Control group had a 6.0% incidence of fatal pulmonary embolism versus 0.1% in the heparin group (p < 0.005)
Deep vein thrombosis reduced from 25% in control to 7% in heparin group
No significant difference in blood transfusion rates or hemoglobin levels between groups.

Structured PICO

Does low-dose heparin prevent fatal pulmonary embolism and deep vein thrombosis in patients undergoing major surgery?

Population

Patients undergoing major surgery (general abdominal, thoracic, urological, and total hip replacement), including a highlighted multicenter trial of n=4,121 patients.

Intervention

Low-dose heparin

Comparator

Control group

Outcome

Fatal pulmonary embolism proved at autopsyhard clinical

Low-dose heparin prophylaxis significantly reduces the incidence of fatal pulmonary embolism and deep vein thrombosis after major surgery without significantly increasing bleeding risk.

Limitations

Less evidence of benefit in patients undergoing total hip replacement

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Supports low-dose heparin prophylaxis in major surgery; reinforces consensus from 27 prior trials.

Cite This Study

V V Kakkar (1978) studied this question.

synapsesocial.com/papers/6a1d1fa073c56dd1bd2f388d https://doi.org/10.1007/bf01574449

Topics

Pulmonary embolism

View Full Paper

Ask AI

Bookmark

The current status of low‐dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism

Key Points

Structured PICO

Limitations

Discussion

Implication

Cite This Study

Topics

The current status of low‐dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism

Key Points

Structured PICO

Limitations

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider